Fluorescence polarization in nucleic acid analysis

ABSTRACT

A new method for DNA diagnostics based on template-directed primer extension and detection by fluorescence polarization is described. In this method, amplified genomic DNA fragments containing polymorphic sites are incubated with a oligonucleotide primer designed to hybridize to the DNA template adjacent to the polymorphic site in the presence of allelic dye-labeled dideoxyribonucleoside triphosphates and a modified Taq DNA polymerase. The primer is extended by the dye-terminator specific for the allele present on the template. At the end of the reaction, the fluorescence polarization of the two dye-terminators in the reaction mixture are analyzed directly without separation or purification. This homogeneous DNA diagnostic method is shown to be highly sensitive and specific and is suitable for automated genotyping of large number or samples.

This application is a continuing application of Ser. No. 09/137,826filed Aug. 21, 1998 now U.S. Pat. No. 6,180,408 Jan. 30, 2001. Thecontents of that application are incorporated herein by reference.

STATEMENT OF RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSOREDRESEARCH

The experimental work disclosed herein was supported in part under U.S.Department of Health and Human Services, National Institutes of Healthfunding agreements: 1F32-HG00156 and 1RO1-HG01720.

TECHNICAL FIELD OF THE INVENTION

This invention relates to new diagnostic methods and diagnostic kits forthe analysis of DNA using template-directed primer extension and highlysensitive detection by fluorescence polarization. This invention furtherrelates to methods of identifying single nucleotide polymorphisms (SNPs)as well as other DNA sequence variations. Also, this invention relatesbroadly to the fields of biotechnology, molecular genetics andbiomedicine.

BACKGROUND OF THE INVENTION

DNA analysis is becoming increasingly important in the diagnosis ofhereditary diseases, detection of infectious agents, tissue typing forhistocompatability, identification of individuals in forensic andpaternity testing, and monitoring the genetic makeup of plants andanimals in agricultural research (Alford, R. L., et al., Curr Opn.Biotechnol (1994) 5:29-33). In addition, DNA analysis is crucial inlarge-scale genetic studies to identify susceptibility allelesassociated with common diseases involving multiple genetic andenvironmental factors (Risch, N., et al., Science (1996) 273:1516-1517).Recently, attention is focused on single nucleotide polymorphisms(SNPs), the most common DNA sequence variation found in mammaliangenomes (Cooper, D. N., et al., Hum Genet (1985) 69:201-205). While mostof the SNPs do not give rise to detectable phenotypes, a significantfraction of them are disease-causing mutations responsible for geneticdiseases. As the DNA sequence of the human genome is completelyelucidated, large-scale DNA analysis will play a crucial role indetermining the relationship between genotype (DNA sequence) andphenotype (disease and health) (Cooper, D. N., et al., Hum Genet (1988)78:299-312). Although some assays have considerable promise for highthroughput, the recently developed DNA diagnostic methods, including thehigh-density chip arrays for allele-specific hybridization analysis(Pease, A. C., et al., Proc Natl Acad Sci USA (1994) 91:5022-5026;Yershov, G., et al., Proc Natl Acad Sci USA (1996) 93:4913-4918), Wang,D. G., et al., Science (1998) 280:1077-1081, the homogeneous 5′-nucleaseallele-specific oligonucleotide cleavage assay (TaqMan ASO, Livak, K.J., et al., Nat Genet (1995) 9:341-342), Whitcombe, D., et al., ClinChem (1998) 44:918-923 a homogeneous fluorescence assay for PCRamplifications: its application to real-time, single-tube genotyping,the homogeneous template-directed dye-terminator incorporation (TDI)assay (Chen, X., et al., Nucleic Acids Res (1997) 25:347-353; Chen, X.,et al., Proc Natl Acad Sci USA (1997) 94:10756-10761) the homogeneousdye-labeled oligonucleotide ligation (DOL) assay (Chen, X. et al. GenomeResearch (1998) 8: 549-556.), and the homogeneous molecular beacon ASOassay (Tyagi, S. et al. Nature Biotechnology (1998) 16: 49-53), allrequire specialty reagents and expensive detection instrumentation.

All the DNA diagnostic methods listed above involve amplification oftarget sequences to increase the sensitivity and specificity of theassays through polymerase chain reaction (PCR) or other similaramplification technologies. For example, one of the best knownamplification methods is the polymerase chain reaction (referred to asPCR) which is described in detail in U.S. Pat. Nos. 4,683,195, 4,683,202and 4,800,159. Briefly, in PCR, two primer sequences are prepared whichare complementary to regions on opposite complementary strands of thetarget sequence. An excess of deoxynucleoside triphosphates are added toa reaction mixture along with a thermostable DNA polymerase (e.g., Taqpolymerase). If the target sequence is present in a sample, the primerswill bind to the target and the polymerase will cause the primers to beextended along the target sequence by adding on nucleotides. By raisingand lowering the temperature of the reaction mixture, the extendedprimers reaction products will dissociate from the target to become newtargets. The excess primers will bind to the target and to the reactionproducts and the process is repeated. Other technologies result inamplification of a target sequence by strand displacement. Thesetechniques include an enzymatic “nicking” or preferential cleavage ofone of two strands present in a double-stranded DNA recognition site andthe separation or detection of amplified products that include thetarget site, which is presented in U.S. Pat. Nos. 5,270,184. and5,455,166 and each of which is hereby incorporated by reference herein.

Still other techniques employ the use of a fluorescently labeled primerand detect fluorescence or fluorescence polarization after the primer ishybridized to the target region, which is presented in U.S. Pat. No.5,593,867. In U.S. Pat. No. 5,641,633, double-stranded DNA bindingprotein is also used to further preserve the hybridization of thefluorescently labeled primer to the target site. These methods requirethe use of fluorescently labeled primers and their detection whilehybridized to the target site.

Template-directed primer extension is a dideoxy chain terminating DNAsequencing protocol designed to ascertain the nature of the one baseimmediately 3′ to the sequencing primer that is annealed to the targetDNA immediately upstream from the polymorphic site. In the presence ofDNA polymerase and the appropriate dideoxyribonucleoside triphosphate(ddNTP), the primer is extended specifically by one base as dictated bythe target DNA sequence at the polymorphic site. By determining whichddNTP is incorporated, the allele(s) present in the target DNA can beinferred. This genotyping method has been widely used in many differentformats and proven to be highly sensitive and specific (Syvanen, A.-C etal, Genomics (1990) 8: 684-692; Syvanen, A.-C. and Landegren, U. HumanMutation (1994) 3: 172-179).

Fluorescence polarization (FP) is based on the observation that when afluorescent molecule is excited by plane-polarized light, it emitspolarized fluorescent light into a fixed plane if the molecules remainstationary between excitation and emission (FIG. 1). Because themolecule rotates and tumbles in space during the fluorescent decay time,however, FP is not observed fully by an external detector. The observedFP of a fluorescent species is described by the Perrin equation and isrelated to the ratio of the rotational relaxation time and thefluorescent lifetime. If the temperature and viscosity are held constantthe rotational relaxation time is proportional to the molecular volumeof the fluorescent species. If local rotational motion of thefluorophore is minimal the FP is directly proportional to the molecularweight. In other words, when a fluorescent molecule and its conjugateare large (with high molecular weight), it rotates and tumbles slowly insolution compared to the fluorescent lifetime and FP is preserved. Ifthe molecule is small (with low molecular weight), it rotates andtumbles faster and FP is largely lost (depolarized). The FP phenomenonhas been used to study protein-DNA and protein-protein interactions(Dunkak, K. S. et al., Anal. Biochem. (1996) 243: 234-244; Heyduk, T. etal. Methods Enzymol. (1996) 274: 492-503; Wu, P. et al., Anal. Biochem.(1997) 249: 29-36), DNA detection by strand displacement amplification(Walker, G. T. et al., Nucleic Acids Res. (1996) 24: 348-353), and ingenotyping by hybridization (Gibson, N. J. et al., Clin. Chem. (1997)43: 1336-1341). More than 50 fluorescence polarization immunoassays(FPIA) are currently commercially available, many of which are routinelyused in clinical laboratories for the measurement of therapeutics,metabolites, and drugs of abuse in biological fluids (Checovich, W. J.,et al., Nature (1995) 375:254-256).

FP is expressed as the ratio of fluorescence detected in the verticaland horizontal axes and is therefore independent of the totalfluorescence intensity. This is a clear advantage over otherfluorescence detection methods in that as long as the fluorescence isabove detection limits of the instrument used, FP is a reliable measure.The FP difference between totally bound and totally unbound fluorescentspecies represents the total dynamic range possible for the system. Aslong as a statistically significant difference can be experimentallyderived by the interaction of a fluorophore attached to a low molecularweight species and its complexation or incorporation into a highermolecular weight species, FP represents a suitable detection scheme forthe chemistry occurring in solution. This is normally empiricallyderived as local motions in the fluorescently-tagged species make itdifficult to theoretically predict a suitable probe.

The total polarization reflects the sum of FP from all species insolution emitting at that wavelength. For a system in which thefluorophore is attached to a low molecular weight nucleotide producing alow polarization and is then incorporated into the probe oligomer at theallelic site, the polarization observed is described by the equation:

P=P _(max) [ddNTP] _(b) +P _(min)([ddNTP] _(i) −[ddNTP] _(b))

where P_(max) is the polarization for dye-labeled ddNTP incorporatedonto the TDI probe, P_(min) is the polarization of the unincorporateddye-labeled ddNTP, [ddNTP]_(i) is the initial concentration ofdye-labeled ddNTP, and [ddNTP]_(b) is the concentration of incorporateddye-labeled ddNTP. The maximum change in signal occurs with 100%incorporation of the ddNTP. Therefore, an important aspect inexperimental design is to ensure that the initial concentration ofdye-labeled ddNTP used in the reaction is kept at a minimum.

While the separate use of fluorescence polarization and TDI technologieshave been reported, the effective use of these technologies together asdisclosed herein has not been realized for many reasons. The sensitivityof instrumentation to enable the accurate observation of fluorescencepolarization has significantly increased over the past several years.Additionally, the present inventors have conducted experimentation anddevelopment to refine the technologies and overcome initially negativeobservations that may have been seen by others leading them away fromthe present invention. The present invention is clearly novel andnon-obvious over the prior teachings in the art because of the presentinvention's ability to synthesize at the target site afluorescently-labeled oligonucleotide comprising a fluorophore linked toa nucleotide and then detect fluorescence polarization of thefluorescently-labeled oligonucleotide in a host of ways which thepresent disclosure makes clear.

All publications cited are incorporated in their entirety by referenceherein.

SUMMARY OF THE INVENTION

The present inventors have determined that the modification in thedetection strategy for the TDI assay that they have developed allows forthe rapid analysis of DNA sequence variations, including SNPs and uniqueinsertions/deletions, in a homogeneous assay using an unmodifiedoligonucleotide probe, which eliminates the need for specialty reagentsor expensive instruments. This present approach combines the specificityof enzymatic discrimination between the two alleles of a DNA sequencevariation in a template-directed primer extension reaction and the highdegree of sensitivity of fluorescence polarization.

This present method, designated template-directed dye-terminatorincorporation assay with FP detection (“FP-TDI” assay; as presented inFIG. 2), provides that the sequencing primer is an unmodified primerwith its 3′-end immediately upstream from the polymorphic or mutationsite. The allele-specific dye-labeled ddNTP is incorporated onto the TDIprimer in the presence of DNA polymerase and target DNA, when incubatedin the presence of ddNTPs labeled with any fluorophore. Manyfluorophores are readily available to the skilled artisan and include,for example, FAM (5-carboxy-fluorescein), ROX (6-carboxy-X-rhodamine),TMR (N,N′,N′-tetramethyl-6-carboxyrhodamine), and BODIPY dyes. Thegenotype of the target DNA molecule can be determined simply by excitingthe dye on the sequencing primer and observing for FP (see FIG. 2).

As will be further disclosed herein, the present inventors havedemonstrated that FP is a simple, highly sensitive, and specificdetection method that may be used in a homogeneous primer extensiongenotyping assay. Both single-stranded synthetic DNA oligomers anddouble-stranded DNA fragments, including those amplified, for example,by the polymerase chain reaction (PCR, Saiki, R. K., et al., Science(1988) 239:487-491) may be used as templates in this assay. In allcases, the FP-TDI assay proves to be highly sensitive and specific.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates the process of fluorescence polarization detection.

FIG. 2 illustrates the process of fluorescence polarizationtemplate-directed dye-terminator incorporation (FP-TDI) assay.

DETAILED DESCRIPTION OF THE INVENTION

In one embodiment, the present invention relates to a method fordetecting the presence of a target site of at least one nucleotide in anucleic acid comprising: (a) forming an oligonucleotide bound to thetarget site wherein the oligonucleotide comprises a fluorophore linkedto a nucleotide therein; and (b) detecting fluorescence polarization ofthe fluorescently-labeled oligonucleotide more preferably detecting anincrease in fluorescence polarization. In a more preferred embodiment,the present invention provides a method for detecting the target site ofsteps (a) and (b) described supra, wherein the oligonucleotide is formedfrom a polynucleotide immediately 3′ on the template to the target siteand a dideoxynucleoside triphosphate (ddNTP) covalently linked to afluorophore, and wherein at least one ddNTP-linked fluorophore binds tothe target site and reacts with the polynucleotide to produce a 3′extension of the polynucleotide. The present invention furthercontemplates the use of more than one ddNTP-linked fluorophore, whereeach fluorophore is unique and may be uniquely observed usingfluorescence polarization.

Another embodiment of the present invention includes a method todiagnose genetic polymorphisms, including single nucleotidepolymorphisms and unique insertions/deletions. This diagnostic methodassays genomic DNA or DNA prepared from RNA isolated from a sample ofbiological material from a subject. This assay utilizes the presentmethod of (a) selecting a sample of biological material from a subjectfor testing for genetic polymorphisms; (b) isolating genomic DNA or RNAfrom the biological material, wherein the genomic DNA or DNA preparedfrom the RNA comprises one or more target sites, and wherein each targetsite comprises a genetic polymorphism; (c) forming an oligonucleotidebound to the target site wherein the oligonucleotide comprises afluorophore linked to a nucleotide therein; (d) detecting fluorescencepolarization of the fluorescently-labeled oligonucleotide; and (e)identifying said genetic polymorphism by said fluorescence polarization.The genetic polymorphism may include a single nucleotide polymorphismand unique insertions/deletions. Further, this embodiment of the presentmethod include the formation of the oligonucleotide from apolynucleotide immediately 3′ on the template to the target site and addNTP covalently linked to a fluorophore, and wherein at least oneddNTP-linked fluorophore binds to the target site and reacts with thepolynucleotide to produce a 3′ extension of the polynucleotide. A morepreferred embodiment include the detection of the fluorescently-labeledoligonucleotide by an increase in fluorescence polarization. Thisembodiment of the present invention further contemplates the use of morethan one ddNTP-linked fluorophore, where each fluorophore is unique andmay be uniquely observed using fluorescence polarization.

Still another embodiment of the present invention, include a diagnostickit for detecting the presence of a target site of at least onenucleotide in a nucleic acid comprising: (a) an oligonucleotide primerdesigned to hybridize to a DNA template immediately 3′ on the templateto the target site; (b) at least one allelic specific ddNTP covalentlylinked to a fluorophore; and (c) a DNA polymerase that reacts with theoligonucleotide primer and the ddNTP to produce a 3′ extension of apolynucleotide. A preferred embodiment of the present inventioncontemplates that the oligonucleotide primer contains about 5-100nucleotides. A more preferred embodiment of the present inventioncontemplates that the oligonucleotide primer contains about 10-50nucleotides. A further preferred embodiment of the present inventionincludes more than one allelic specific ddNTP and that each allelicspecific ddNTP is covalently linked to a unique fluorophore.

Another embodiment of this invention includes the genetic sequence of atarget site detected by any one of the methods discussed supra.

Still a further embodiment of the present invention includes a methodfor detecting the presence of a target site of at least one nucleotidein a nucleic acid comprising: (a) synthesizing at the target site afluorescently-labeled oligonucleotide comprising a fluorophore linked toa nucleotide; and (b) detecting fluorescence polarization of thefluorescently-labeled oligonucleotide. A preferred embodiment includesthe practice of this method, wherein the fluorescence polarization ofthe fluorescently-labeled oligonucleotide is detected in the absence andthe presence of a single stranded DNA binding (SSB) protein. Anotherpreferred embodiment provides the practice of this method, wherein thefluorescence polarization of the fluorescently-labeled oligonucleotideis detected in the absence and the presence of an organic solvent.

Of course, this invention further contemplates the practice of themethod, wherein the fluorescence polarization of thefluorescently-labeled oligonucleotide is detected in the absence and thepresence of a single stranded DNA binding (SSB) protein as well as anorganic solvent.

The selection of specific fluorophore would include those readily knownto the ordinary skilled artisan. Other fluorophores may be subsequentlydeveloped and selected provided that a fluorophore employed iscovalently linked to a ddNTP and produces a signal detectable byfluorescence polarization. Such fluorophores contemplated in the presentinvention, include, but are not limited to: 5-carboxyfluorescein(FAM-ddNTPs); 6-carboxy-X-rhodamine (ROX-ddNTPs);N,N,N′,N′-tetramethyl-6-carboxyrhodamine (TMR-ddNTPs); and BODIPY-TexasRed (BTR-ddNTPs).

The selection of templates and primers that may be used with the presentmethod is well within the ordinary skill in the art. The synthetictemplates presented herein are merely by way of example and include:CF508-48A; CF508-48C; CF508-48G; and CF508-48T. The selection of anytemplate, synthetic or otherwise, may be based upon the preferentialdegree of hybridization between the template and the primer and thepresence of a target site on the template.

The application of this method to genomic DNA as well as DNA preparedfrom RNA isolated from a sample of biological material taken from asubject is without limit. Techniques that may be employed for theisolation of genomic DNA as well as techniques for the preparation ofDNA from isolated RNA are also well known. For example, U.S. Pat No.5,270,184, which is hereby incorporated in its entirety by referenceherein, presents several techniques for the isolation of DNA. A samplemay be isolated from any material suspected of containing the targetnucleic acid sequence. For animals, preferably, mammals, and morepreferably humans, the sources of such materials may comprise blood,bone marrow, lymph, hard tissues (e.g., liver, spleen, kidney, lung,ovary, etc.), sputum, feces and urine. Other sources of material may bederived from plants, soil and other materials suspected of containingbiological organisms. The isolation of nucleic acids from thesematerials can be performed in any number of ways. Such methods includethe use of detergent lysates, sonication, vortexing with glass beads anda French press. In some instances, it may be advantageous to purify thenucleic acids isolated (e.g., where endogenous nucleases are present).In those instances, purification of the nucleic acids may beaccomplished by phenol extraction, chromatography, ion exchange, gelelectrophoresis or density dependent centrifugation. Once the nucleicacids are isolated, it will be assumed for purposes of illustrationherein only that the genomic nucleic acid is DNA and is double stranded.

Terms as used herein are based upon their art recognized meaning andshould be clearly understood by the ordinary skilled artisan. Forexample, a target site is meant to include any region of DNA that may bedetected using the present method. Genetic polymorphisms include thepresence of differing genetic sequences or genes that map at the samelocus or allele in all individual subjects of the same species. Suchgenetic variation may not result in differing phenotypic expression, butappears as genetic difference among individual subjects.

General Methodology

Brief Description

The FP-TDI assay involves 4 steps (see FIG. 2). First, the DNA target isamplified from the source DNA by PCR using a thermostable DNApolymerase. Second, the excess PCR primer and deoxynucleosidetriphosphates (dNTPs) are degraded by a thermolabile enzyme thatdegrades single-stranded DNA (such as the E. coli exonuclease I or mungbean nuclease) and a thermolabile enzyme that degrades dNTPs (such asthe shrimp alkaline phosphatase or HK thermolabile phosphatase),respectively. Third, the two enzymes are heat-inactivated. Fourth, theTDI primer, the allele-specific dye-labeled ddNTPs, and a mutantthermostable DNA polymerase with improved efficiency for incorporatingdye-labeled terminators (such as AmpliTaq, FS DNA polymerase or ThermoSequenase) are added for the TDI reaction with thermal cycling.

At the end of the reaction, dilution buffer is added to the reactionmixture before it is transferred to a microtiter plate for measure offluorescence polarization on a fluorescence polarization plate reader.In instances where hydrophobic dyes are employed, an organic solvent,such as methanol, may be used to reduce non-specific backgroundpolarization.

Enzymes

AmpliTaq® and Taq-FS DNA polymerase were obtained from Perkin-ElmerApplied Biosystems Division (Foster City, Calif.). Shrimp alkalinephosphotase, single stranded DNA binding protein (SSB) and E. coliexonuclease I were purchased from Amersham (Arlington Heights, Ill).

Oligonucleotides

Oligonucleotides used are listed in Table 1. PCR and TDI primers andsynthetic template oligonucleotides were obtained commercially (LifeTechnologies, Grand Island, N.Y.).

TABLE 1 Synthetic templates and primers used in the FP-TDI studiesOligonucleotides Sequence (5′ to 3′) Synthetic Templates CF508-48AATATTCATCATAGGAAACACCAAAGATGATATTTTCTTTAATGGTGC C (SEQ ID NO:1)CF508-48C ATATTCATCATAGGAAACACCACAGATGATATTTTCTTTAATGGTGC C (SEQ IDNO:2) CF508-48G ATATTCATCATAGGAAACACCAGAGATGATATTTTCTTTAATGGTGC C (SEQID NO:3) CF508-48T ATATTCATCATAGGAAACACCATAGATGATATTTTCTTTAATGGTGC C(SEQ ID NO:4) PCR Primers CF508-p1 GTGCATAGCAGAGTACCTGAAACAGGAAGTA (SEQID NO:5) CF508-p2 TGATCCATTCACAGTAGCTTACCCATAGAGG (SEQ ID NO:6) DXS17-p1GGTACATGACAATCTCCCAATAT (SEQ ID NO:7) DXS17-p2 GCAATTATCTGTATTACTTGAAT(SEQ ID NO:8) FP-TDI Primers CP508-25 GGCACCATTAAAGAAAATATCATCT (SEQ IDNO:9) DXS17-A TTACAGAGTGTAATTGGATTATTTGTAACTC (SEQ ID NO:10) DXS17-BCCCTTATGCACTTATCCTT (SEQ ID NO:11)

Dideoxyribonucleoside Triphosphates

Dideoxyribonucleoside triphosphates labeled with 5-carboxy-fluorescein(FAM-ddNTPs), 6-carboxy-X-rhodamine (ROX-ddNTPs),N,N,N′,N′-tetramethyl-6-carboxyrhodamine (TMR-ddNTPs) and BODIPY-TexasRed (BTR-ddNTPs) were obtained from NEN Life Science Products, Inc.(Boston, Mass.). Unlabeled ddNTPs were purchased from Pharmacia Biotech(Piscataway, N.J.).

Fluorescence Polarization Measurement

After the primer extension reaction, 125 μL of TDI buffer were added toeach tube before they were transferred to a microtiter plate for FPmeasurement on a Fluorolite FPM2 instrument (Jolley Consulting andResearch, Grayslake, Ill.). Fluorescence polarization value wascalculated using the formula:

P=[Ivv−Ivh]/[Ivv+Ivh]

where Ivv is the emission intensity measured when the excitation andemission polarizers are parallel and Ivh is the emission intensitymeasured when the emission and excitation polarizers are orientedperpendicular to each other.

Genotype Assignment

The average FP value and standard deviation of the quadruplicatenegative control samples were determined for each set of experiment. Theaverage FP value of the quadruplicate test sample reactions was thencompared to that of the control samples. If the net change is >5 timesthe standard deviation of the controls, the test sample is scored aspositive for the allele.

EXAMPLES

The following examples show that FP is a simple, highly sensitive andspecific detection method in a homogeneous primer extension reaction forsingle base pair changes.

Having now generally described the invention, the same will be morereadily understood through reference to the following examples which areprovided by way of illustration, and are not intended to be limiting ofthe present invention, unless specified.

Example 1 DNA typing by the FP-TDI assay with synthetic templates

Four synthetic 48-mers with identical sequence except for position 23,where each of the four possible bases were represented in each of the 4different synthetic templates (CF508-48, shown as bold-face letters inTable 1), were prepared. Each synthetic 48-mer served as template in 4separate reactions where it was incubated with the 25-mer FP-TDI primer(CF508-25) and one of the 4 FAM-labeled terminators in the presence ofAmpliTaq DNA polymerase, FS. The reactions were carried out in 20 μLreaction volume, containing 250 nM templates, 500 nM FP-TDI probeCF508-25, 250 nM FAM-ddNTP, 1.0 unit of AmpliTaq-FS, 50 mM Tris-HCl, pH9.0, 50 mM KCl, 5 mM MgCl₂, 8% glycerol, 0.1% Triton X-100. Reactionmixtures were thermal-cycled 25 times between 95° C., 30 seconds, 45° C.30 seconds. At the end of the TDI reaction, the reaction mixture wasdiluted in 125 μL of reaction buffer (50 mM Tris-HCl, pH 9.0, 50 mM KCl,5 mM MgCl₂, 8% glycerol, 0.1% Triton X-100) and the fluorescencepolarization was measured on Flourolite FPM2 (Jolley Consulting andResearch, Inc., Grayslake, Ill.).

Table 2 shows the results of these experiments. In all cases, only theterminator complementary to the polymorphic base was incorporated andshowed significant FP change, with net gains of FP of at least 50 mP (>9times standard deviation of controls). This example demonstrates theprinciple that fluorescence polarization can be used as a tool to detectgenotypes using TDI protocols.

TABLE 2 FP-TDI assay with synthetic templates using different dyeterminators FAM-ddA FAM-ddC FAM-ddG FAM-ddU Templates (mP)^(a) (mP)^(a)(mP)^(a) (mP)^(a) CF508-48A 52 36 54 89 55 37 41 92 52 39 48 101 50 3940 93 CF508-48C 57 37 121 39 50 37 126 30 55 39 115 40 52 34 117 40CF508-48G 52 92 42 42 63 85 35 32 50 91 40 47 49 103 37 35 CF508-48T 18632 48 34 180 38 63 41 183 36 43 33 179 33 55 45 Avg. Ctrl. 53 36 46 38Std. Dev. Ctrl. 4.0 2.5 8.3 5.3 Avg. Net Chg.^(b) 129 57 74 55 ^(a)FPmeasurements for FAM were made with excitation at 485 nm and monitoredat 530 nm. ^(b)Net change over average of controls.

Example 2 FP-TDI Assay with Different Terminators Labeled with DifferentDyes

In an effort to identify different dyes suitable for multi-colordetection in the same reaction, a number of different dyes were studiedfor their FP properties in the FP-TDI assay. The experimental protocolas provided in Example 1 was followed, except that a different set ofdye-labeled ddNTPs were used for each testing dye.

Each of the combinations of dye-terminators were tested and the optimalset of terminators were determined chosen based upon the minimalstandard deviations in the control samples and large net changes in thepositive samples. These combinations of dye-terminators were found to beFAM-ddA, TMR-ddC, ROX-ddG, and BTR-ddU (see Table 3). In all of thesecases, the net rise in FP exceeded 15 times standard deviation of themean of the control samples. In addition, ROX-ddA, BTR-ddC, TMR-ddU, andall FAM terminators were also found to work well.

TABLE 3 FP-TDI assay with synthetic templates using different dyeterminators FAM-ddA TMR-ddC ROX-ddG BTR-ddU Templates (mP)^(a) (mP)^(a)(mP)^(a) (mP)^(a) CF508-48A 52 43 77 174 55 53 73 175 52 36 78 174 50 4982 170 CF508-48C 57 50 214 32 50 37 209 27 55 56 215 25 52 38 207 26CF508-48G 52 247 84 23 63 266 80 30 50 253 75 23 49 262 74 21 CF508-48T186 52 81 32 180 41 68 39 183 59 81 30 179 32 76 28 Avg. Ctrl. 53 46 8628 Std. Dev. Ctrl. 4.0 8.8 4.6 5.0 Avg. Net Chg.^(b) 129 211 134 145^(a)FP measurements for FAM were made with excitation at 485 nm andmonitored at 530 nm, those for TMR were made with excitation at 535 nmand monitored at 590 nm, while those for ROX and BTR were made withexcitation at 591 nm and monitored at 635 nm. ^(b)Net change overaverage of control.

Example 3 One Color FP-DI Assay for Amplified Genomic DNA

In this example, a genetic marker, DXS17 (Kornreich, R., et al.,Genomics (1992) 13:70-74) with an A/G polymorphism was used to test theFP-TDI genotyping for PCR amplified genomic DNA fragments.

PCR amplification

Human genomic DNA (20ng) from at least 8 unrelated individuals wereamplified in 20 μL reaction mixtures containing 10 mM Tris-HCl, pH 8.3,50 mM KCl, 1.5 mM MgCl₂, 0.2 mM dNTP, 1 μM of each primer, dxs17-p1 anddxs17-p2, and AmpliTaq DNA polymerase (1U). The reaction mixture washeld at 94° C. for 2 min, followed by 10 cycles of 94° C. for 10 sec.,ramping to 60° C. over 90 sec., held at 60° C. for 30 sec., followed by30 cycles of 94° C. for 10 sec. and 53° C. for 30 sec. the end of thereaction, the reaction mixture was cooled to 4° C. to await furthermanipulations.

Primer and dNTP degradation

At the end of the PCR assay, 10 μL of an enzymatic cocktail containingshrimp alkaline phosphatase (2U), E. coli exonuclease I (1U) in shrimpalkaline phosphatase buffer (20 mM Tris-HCl, pH 8.0, 10 mM MgCl₂) wasadded to the PCR product. The mixture was incubated at 37° C. for 30min. before the enzymes were heat inactivated at 95° C. for 15 min. TheDNA mixture was kept at 4° C. and was used in the FP-TDI assay withoutfurther quantification or characterization.

Genotyping by the FP-TDI assay

After PCR primer and dNTP degradation, aliquots of the PCR mixture (10μL) were distributed into two new reaction tubes for parallel assays ofallele 1 and allele 2 using TDI primer dxs17-A. 10 μL of TDI reactionmixture containing the TDI buffer (50 mM Tris-HCl, pH 9.0, 50 mM KCl, 5mM MgCl₂, 8% glycerol, 0.1% Triton X-100), 1.25 μM TDI primer, 25 nMdye-labeled ddATP (allele 1) or ddGTP (allele 2), and 1 unit ofAmpliTaq-FS DNA polymerase were added to each of these two sets ofreaction. The reaction mixtures were then incubated at 93° C. for 1 min,followed by 35 cycles of 93° C. for 10 sec and 50° C. for 30 sec. At theend of the reaction, the samples were held at 4° C.

As shown in Table 4, the FP values of the samples when incubated withFAM-ddA and FAM-ddG fell into discrete categories. Samples 1-4 and 7-8had FP values >40 mP above the average control values (>20 timesstandard deviation of controls) in the FAM-ddA reactions. Similarly,samples 1, 3-6, and 8 had FP values >40 mP above the average controlvalues (>8 times standard deviation of controls) in the FAM-ddGreactions. Simply by scoring as positive reactions with net FP changesof >40 mP yielded the genotypes that were in total agreement with thosedetermined using other means.

TABLE 4 Single color FP-TDI assay to genotype marker DXS17 with PCRproducts as templates FAM-ddA FAM-ddG Genotype Sample (mP)^(a) (mP)^(a)Predicted Observed 1 108 85 A/G A/G 2 111 49 A/A A/A 3 113 85 A/G A/G 4114 97 A/G A/G 5 45 91 G/G G/G 6 50 90 G/G G/G 7 128 40 A/A A/A 8 109 91A/G A/G Avg. Ctrl. 64 42 Std. Dev. Ctrl 2.0 4.9 ^(a)See footnote inTable 3 for excitation and emission wavelengths used.

Example 4 Two Color FP-TDI Assay for Synthetic Templates

To show that one could test for both alleles of a marker in a singlereaction, synthetic templates CF508-48 bearing the “A” and “G” alleleswere used as a testing with BTR-ddU and TMR-ddC terminators. Theexperiments followed the research protocols provided in Example 1, withfollowing differences: (1) for a simulated heterozygote reaction, bothtemplates CF508-48A and CF508-48G were (2) to each reaction, bothBTR-ddU and TMR-ddC were used.

Four sets of reactions were carried out: samples containing the “A”template alone, “G” template alone, both “A” and “G” templates at halfconcentrations, and no templates. All reactions were performed inquadruplicates and two FP measurements were made for each reactionmixture to determine their FP values for BTR and TMR. Table 5 shows theresults of these experiments. As expected, significant FP changes werefound for BTR only in reactions where BTR-ddU and templates containingthe “A” allele were incubated together (“homozygous A” and “heterozygousA/G”). Similarly, significant FP changes for TMR were found only inreactions where TMR-ddC and templates containing the “G” allele wereincubated together (“homozygous G” and “heterozygous A/G”). In reactionswhere the dye-terminators were not complementary to the templates, nosignificant change in FP was observed (e.g., TMR-ddC in the “homozygousA” reaction and BTR-ddU in the “homozygous G” reaction).

TABLE 5 Dual color FP-TDI assay witb synthetic templates^(a) TemplatesCF508-48A CF508-48A/G CF408-48G Blank Dye-terminator TMR-C BTR-U TMR-CBTR-U TMR-C BTR-U TMR-C BTR-U Samples 1-4 66 148 198 130 242 21 50 23Samples 5-8 65 142 180 139 242 40 57 20 Samples 9-12 64 141 163 127 24227 47 18 Samples 13-16 66 146 135 100 232 29 54 28 Average 65 144 169124 240 29 52 22 Net Change^(b) 13 122 117 102 188  5 Std. Dev. 4.3 4.2^(a)See footnote in Table 3 for excitation and emission wavelengthsused. ^(b)Net change over average of control.

Example 5 Two Color FP-TDI Assay for Amplified Genomic DNA

Marker DXS17 was used in a FP-TDI assay designed to test for bothalleles in the same reaction. PCR amplification of Genomic DNA,enzymatic degradation of excess dNTPs and PCR primers were carried outas provided in Example 3. After enzymatic clean-up, 10 μL of TDI mixturecontaining the TDI buffer (50 mM Tris-HCl, pH 9.0, 50 mM KCl, 5 mMMgCl₂, 8% glycerol, 0.1% Triton X-100), 1.25 μM DXS17-B, 25 nM TMR-ddC(allele 1) and BTR-ddU (allele 2), and 1 unit of AmpliTaq-FS DNApolymerase were added to each tube. Reaction mixture was incubated at93° C. for 1 min, followed by 35 cycles of 93° C. for 10 sec and 50° C.for 30 sec. At the end of the reaction, the samples were held at 4° C.

Fluorescence intensities for both TMR and BTR were measured separatelyat the TMR and BTR emission wavelengths. FP values for TMR and BTR werecalculated respectively. These results are shown in Table 6. Thepositive samples in the TMR reaction gave FP values that were >80 mPabove control while the positive samples in the BTR reaction gave FPvalues that were >25 mP above control (>7 times standard deviation ofthe controls). The genotypes of the samples were easily determined andwere listed in the Table. These results were in complete concordancewith those obtained by other genotyping methods.

TABLE 6 Dual color FP-TDI assay to genotype marker DXS17 with PCRproducts as templates Sample TMR-C(mP)^(a) BTR-T(mP)^(a) PredictedObserved 1 149 130 C/T C/T 2 146 125 C/T C/T 3 174 148 C/T C/T 4 149 130C/T C/T 5 173 100 C/C C/C 6 70 138 T/T T/T 7 73 134 T/T T/T 8 176 100C/C C/C Avg. Ctrl. 64 97 Std. Dev. Ctrl 2.0 3.5 ^(a)See footnote inTable 3 for excitation and emission wavelengths used.

Example 6 FP-TDI Genotyping Enhanced by SSB Protein

In this example, genetic marker DXS17 was used to demonstrate thatsingle stranded DNA binding (SSB) protein enhances the change offluorescence polarization. This enhancement was found to increase thesensitivity and efficiency of the assay.

PCR amplification of genomic DNA, shrimp alkaline phosphatase andexonuclease I digestion were carried out as provided in Example 3. Thegenotyping reaction tested only one allele using FAM-ddA. Following thereaction, the reaction mixture was diluted in TDI reaction buffer asdescribed previously. The fluorescence intensities were measured, andfluorescence polarization values were calculated. Then 1 μL of 3.3 μMSSB protein was added to each well of the microtiter plate. The platewas left undisturbed for 30 minutes. Fluorescence intensities weremeasured and the FP values were calculated again. These results areprovided in Table 7.

Single stranded DNA binding protein specifically enhanced the positivereaction, with very little change in the negative reaction noted. Theseresults suggest that the extension products of TDI reaction remainsingle stranded.

TABLE 7 SSB enhancement of FP-TDI results Sample FP value before addingFP value after adding SSB Change of FP number SSB protein (mP) protein(mP) value (%) result 1 40.55 46.15 13.82 − 2 34.47 39.78 15.41 − 360.20 96.58 60.44 + 4 40.61 48.66 19.81 − 5 130.58 129.08 −1.15 + 629.26 40.39 38.01 − 7 29.77 39.07 31.21 − 8 47.96 53.98 12.54 − 9 110.35111.56 1.10 + 10 124.76 245.65 96.89 + 11 69.64 102.90 47.76 + 12 38.0740.21 5.60 − 13 105.44 180.61 71.29 + 14 48.28 46.41 −3.86 − 15 50.0953.47 6.74 − 16 32.30 33.11 2.52 − 17 53.63 74.28 38.52 + 18 80.63118.26 46.67 + 19 102.05 170.29 66.87 + 20 115.52 201.33 74.28 + 2138.77 44.29 14.23 − 22 96.64 170.87 76.81 + 23 100.68 155.85 54.79 + 24118.77 210.71 77.41 + 25 48.19 49.31 2.32 − 26 51.60 83.92 62.65 + 2737.26 49.11 31.81 − 28 72.84 115.29 58.29 + 29 42.00 46.95 11.77 − 30115.31 212.30 84.12 + 31 29.12 41.56 42.71 − 32 33.80 42.99 27.18 − 3336.21 49.18 35.82 − 34 104.96 197.11 87.81 + 35 102.27 153.87 50.46 + 3626.25 42.13 60.49 − 37 46.17 68.01 47.31 + 38 117.28 176.45 50.46 + 39107.96 199.43 84.73 + 40 103.29 186.29 80.36 − 41 27.26 51.39 88.48 - 4231.34 37.31 19.06 − 43 85.46 143.88 68.36 + 44 118.90 223.15 87.68 + 45102.69 185.46 80.61 + 46 30.82 47.03 52.61 − 47 39.69 51.07 28.67 − 4887.29 161.95 85.53 + 49 119.77 234.92 96.15 + 50 78.46 101.02 28.74 −

Example 7 FP-TDI Enhanced by Dilution in Buffer Containing Methanol

Some fluorescence dyes are highly hydrophobic, and do not appear toprovide a demonstrably adequate emission spectra in aqueous solution.Such aqueous solutions of these dyes may therefore result in anunacceptably high background of fluorescence polarization. This Exampleshows that an organic solvent, such as methanol, can significantlyreduce the high background of fluorescence polarization. Theseexperiments were carried out using the synthetic template CF508 set andBODIPY-Texas Red (BTR) labeled ddNTPs.

The experimental procedures were performed essentially as provided inExample 2. Following completion of reaction of the primer extension, thereaction mixtures were first diluted in 125 μL of TDI reaction buffer,the fluorescence intensities were measured and the FP values werecalculated. Then, 50 μL of methanol were added to each well of themicrotiter plate and the fluorescence intensities were measured again.These results are provided in Table 8 and Table 9.

Before adding methanol to each well, there were virtually no differencesbetween positive and negative reactions noted using BTR-ddA and BTR-ddG,although there were some differences observed using ddC and ddU. Afteradding methanol to each well, the differences between positive andnegative reactions for ddC and ddU increased dramatically, from 59 to143 mP and from 38 to 145 mP respectively. Surprisingly, however, thepositive and negative reactions still did not differ significantly whenddA and ddG were used. These data suggest that certain dyes may producedifferential results. However, the skilled artisan could easily followthese teachings to observe any differential results for any specificdye.

TABLE 8 Fluorescence polarization values before using methanol. BTR-ddABTR-ddC BTR-ddG BTR-ddU Templates (mP)^(a) (mP)^(a) (mP)^(a) (mP)^(a)CF508-48A 190.1 137.5 191.6 181.7 189.7 142.4 178.5 168.5 193.2 136.9186.2 173.6 187.3 126.1 185.9 171.8 CF508-48C 189.9 136.9 191.5 124.9184.5 134.4 188 142.3 188.6 141.4 182.7 130.8 183.1 130 186.8 139.3CF508-48G 182.8 191.4 193.2 152.7 190.8 204.9 179.2 136.9 179.9 181.2193.4 141.6 191.1 199.1 175.8 123.9 CF508-48T 201.5 141.2 188.2 136.5194.1 132.7 193.5 133.8 201.4 135.1 170.1 131.2 189.1 126.6 191.9 132Positive average 196.5 194.2 187.3 173.9 negative average 187.6 135.1185.6 135.5 Net change 8.9 59.1 1.7 38.4

TABLE 9 Fluorescence polarization values after using methanol. BTR-ddABTR-ddC BTR-ddG BTR-ddU Templates (mP)^(a) (mP)^(a) (mP)^(a) (mP)^(a)CF508-48A 177.3 46.79 162.5 174.3 171.7 59.29 178.2 175.2 168.4 72.09178.1 174.3 169.7 86.71 174 169.9 CF508-48C 163.6 77.79 168.5 32.34166.7 47.35 152.2 26.7 166.9 74.39 128.9 25.2 163.6 69.23 135.1 26.14CF508-48G 155.5 183.7 152.2 22.66 172 192.4 139.8 29.52 151.1 186.9135.7 23.21 154.1 189.7 114.7 21.17 CF508-48T 193.6 10.69 162.5 31.59188.7 −3.073 174.2 39.41 191.3 1.538 137.8 30.04 186.9 −5.372 149.227.63 Positive average 190.1 188.2 146.2 173.4 Negative average 165.144.79 154.9 27.97 Net change 25.07 143.4 −8.723 145.4

Summary of the Examples

While dye-labeled dideoxy-terminators have been used extensively insequencing reactions (Kaiser, R. J., et al., Nucleic Acids Res (1989)17:6087-6102; Prober, J. M., et al., Science (1987) 238:336-341) and thesensitivity and specificity of template-directed primer extensiongenotyping methods are well established (Saiki, R. K., et al., Science(1988) 239:487-491; Syvanen, A. C., et al., Genomics (1990) 8:684-692),the use of FP as a detection method in a primer extension reaction hasnot been reported prior to this work. The seven examples provided showthat FP is a simple, highly sensitive and specific detection method in ahomogeneous primer extension reaction for single base pair changes. Inexample 1, four synthetic templates containing the four possiblenucleotides at one particular site in the middle of otherwise identicaloligonucleotides were used to establish the sensitivity and specificityof FP detection of dye-terminator incorporation. In the second example,several dyes were tested for their utility in this assay. In the thirdset example, PCR products amplified from genomic DNA were used astemplates in a single-color FP-TDI assay to show that accurategenotyping data were produced efficiently by this assay. In the fourthexample, synthetic templates were used to show that by selecting theright combinations of dye-terminators, one could perform dual colorFP-TDI assays. In the fifth example, PCR products were used as templatesin a dual-color FP-TDI assay to show that accurate genotyping data wereobtained for both alleles of a marker or mutation in a homogeneousassay. The sixth example shows single stranded DNA binding protein canspecifically enhance positive results in FP-TDI genotyping. The seventhexample has some surprise results, methanol could increase thedifferences between positive and negative reaction for BTR-ddC andBTR-ddU, but has no effect on BTR-ddA and BTR-ddG. This suggests thatnot only the selection of fluorescence dyes, but also the combination ofthe dyes and bases are very important.

These studies demonstrate that the FP-TDI assay is a robust, homogeneousgenetic test that requires no modified primers for its execution whileretains the sensitivity and specificity of the primer extensionreaction. Since the unmodified FP-TDI primer cost is only 20% of that ofa dye-labeled primer, this new detection method is more cost effectivethan other genotyping assays based on dye-labeled probes. Demand for DNAtesting (i.e., assaying for the presence or absence of known DNApolymorphisms or mutations) is expected to increase dramatically in theareas of diagnostics, forensics, and population studies. A homogeneousgenotyping assay such as the FP-TDI assay is highly suitable for largescale genetic studies because it is not limited by a particular reactionformat and it offers the flexibility of using the best markers as theybecome available for a particular application without redesigning orre-fabricating high-density DNA chips. Furthermore, the FP-TDI assay issimple to set up (by adding the standard reagent mixture to the DNAtemplate), the results are obtained in electronic form minutes after theallele-discriminating reaction is performed, and the genotype can beassigned automatically by the use of a simple computer program. Sincethe principle of FP applies to any fluorescent dye, including thoseabsorbing in the infrared region, studies are now underway to identify aset of 4 optimal fluorescent dyes to produce a standard set of reactionconditions suitable for multiplex TDI. As DNA diagnostic tests will nodoubt be performed more and more by clinical rather than researchlaboratories, methods (such as the FP-TDI assay) utilizing standardprotocols that require minimal laboratory skills or manual handling willbe crucial to the clinical practice of medicine in the future.

11 1 48 DNA Artificial Sequence Template CF508-48A 1 atattcatcataggaaacac caaagatgat attttcttta atggtgcc 48 2 48 DNA ArtificialSequence Template CF508-48C 2 atattcatca taggaaacac cacagatgatattttcttta atggtgcc 48 3 48 DNA Artificial Sequence Template CF508-48G 3atattcatca taggaaacac cagagatgat attttcttta atggtgcc 48 4 48 DNAArtificial Sequence Template CF508-48T 4 atattcatca taggaaacaccatagatgat attttcttta atggtgcc 48 5 31 DNA Artificial Sequence PCRPrimer CF508-p1 5 gtgcatagca gagtacctga aacaggaagt a 31 6 31 DNAArtificial Sequence PCR Primer CF508-p2 6 tgatccattc acagtagcttacccatagag g 31 7 23 DNA Artificial Sequence PCR Primer DXS17-p1 7ggtacatgac aatctcccaa tat 23 8 23 DNA Artificial Sequence PCR PrimerDXS17-p2 8 gcaattatct gtattacttg aat 23 9 25 DNA Artificial SequenceFP-TDI Primer CF508-25 9 ggcaccatta aagaaaatat catct 25 10 31 DNAArtificial Sequence FP-TDI Primer DXS17-A 10 ttacagagtg taattggattatttgtaact c 31 11 19 DNA Artificial Sequence FP-TDI Primer DXS17-B 11cccttatgca cttatcctt 19

What is claimed is:
 1. A method for detecting the presence of a targetsite, if present, of at least one nucleotide in a template nucleic acidcomprising: (a) forming an oligonucleotide bound to the target sitewherein the oligonucleotide comprises a fluorophore linked to aterminator contained therein; and (b) detecting fluorescencepolarization of the fluorophore of the fluorescently-labeledoligonucleotide, wherein the oligonucleotide is formed from a primerbound to the template immediately 3′ to the target site and a terminatorcovalently linked to a fluorophore, and wherein said terminator-linkedfluorophore binds to the target site and reacts with the primer toproduce an extended primer which is said fluorescently labeledoligonucleotide, wherein an increase in fluorescence polarizationindicates the presence of the target site thereby detecting the presenceof the target site by said increase in fluorescence polarization.
 2. Themethod of claim 1, wherein said fluorophore is selected from the groupconsisting of: 5-carboxyfluorescein (FAM-ddNTPs); 6-carboxy-X-rhodamine(ROX-ddNTPs); N,N,N′,N′-tetramethyl-6-carboxyrhodamine (TMR-ddNTPs); andBODIPY-Texas Red (BTR-ddNTPs).
 3. The method of claim 1 wherein step (b)is conducted in the presence of a single stranded DNA binding (SSB)protein.
 4. The method of claim 1 wherein step (b) is conducted in thepresence of an organic solvent.
 5. The method of claim 4, wherein theorganic solvent is methanol.
 6. A method of diagnosing the presence of agenetic polymorphism characterized by the presence of a singlenucleotide target site in a subject, comprising: (a) isolating genomicDNA or RNA from a sample of biological material, wherein templategenomic DNA or template DNA prepared from the RNA comprises one or moretarget sites, and wherein each target site comprises a geneticpolymorphism; (b) forming a fluorescently labeled oligonucleotide boundto the target site if present wherein the oligonucleotide comprises afluorophore linked to a terminator contained therein; (c) detectingfluorescence polarization of the fluorophore of thefluorescently-labeled oligonucleotide; wherein the oligonucleotide isformed from a primer bound to the template immediately 3′ to the targetsite and a terminator covalently linked to a fluorophore, and whereinsaid terminator-linked fluorophore binds to the target side and reactswith the primer to produce an extended primer which is saidfluorescently labeled oligonucleotide, wherein an increase influorescence polarization indicates the presence of the target sitethereby detecting the presence of the target site which comprises agenetic polymorphism by said increase in fluorescence polarization. 7.The method of claim 6, wherein said fluorophore is selected from thegroup consisting of: 5-carboxyfluorescein (FAM-ddNTPs);6-carboxy-X-rhodamine (ROX-ddNTPs);N,N,N′,N′-tetramethyl-6-carboxyrhodamine (TMR-ddNTPs); and BODIPY-TexasRed (BTR-ddNTPs).
 8. A method for detecting the presence of specifiednucleotides at a first and second target single nucleotide site in eachof two alleles in templates which comprise amplified genomic DNA whichmethod comprises (a) forming a first fluorescently labeledoligonucleotide from a first primer bound to a first template alleleimmediately 3′ to the target site and a first terminator covalentlylinked to a first fluorophore, and wherein said terminator linkedfluorophore binds to a first target site if present and reacts with theprimer to produce an extended primer which is said first fluorescentlylabeled oligonucleotide, and forming a second fluorescently labeledoligonucleotide from said primer bound to a second template alleleimmediately 3′ to the target site and a second terminator covalentlylinked to a second fluorophore, and wherein said terminator linkedfluorophore binds to a second target site if present and reacts with theprimer to produce an extended primer which is said second fluorescentlylabeled oligonucleotide, and (b) detecting fluorescence polarization ofthe fluorophores of each of said first and second differentlyfluorescently labeled oligonucleotides whereby an increase influorescence polarization of said first fluorophore indicates thepresence of the first target site, and whereby an increase influorescence polarization of said second fluorophore indicates thepresence of the second target site.
 9. The method of claim 8 whereinstep (b) is conducted in the presence of a single stranded DNA binding(SSB) protein.
 10. The method of claim 8 wherein step (b) is conductedin the presence of an organic solvent.
 11. A method for detecting thepresence of a target site of at least one nucleotide in a templatenucleic acid comprising detecting fluorescence polarization of afluorescently labeled oligonucleotide which is bound to the target sitewherein an increase in fluorescence polarization indicates the presenceof the target site, thereby detecting the presence of the target site bysaid increase in fluorescence polarization; and wherein thefluorescently labeled oligonucleotide comprises a fluorophore linked toa terminator therein; and wherein the fluorescently labeledoligonucleotide has been formed from a primer bound to the templateimmediately 3′ to the target site and terminator covalently linked to afluorophore, and wherein said terminator-linked fluorophore binds to thetarget site and reacts with the primer to produce an extended primerwhich is said fluorescently labeled oligonucleotide.
 12. The method ofclaim 11 wherein the template nucleic acid is amplified from the genomeof an organism.